(Q44429714)

2 December 2017

title

Pharmacovigilance study of alendronate in England (English)

1 reference

2 December 2017

Pipasha N. Biswas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730757

30 December 2023

Lynda V. Wilton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730757

30 December 2023

Saad A. W. Shakir

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730757

30 December 2023

language of work or name

English

0 references

publication date

23 April 2003

1 reference

full work available at URL

2 December 2017

http://link.springer.com/content/pdf/10.1007/s00198-003-1399-y.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00198-003-1399-Y

http://link.springer.com/article/10.1007/s00198-003-1399-y/fulltext.html

30 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00198-003-1399-Y

http://link.springer.com/content/pdf/10.1007/s00198-003-1399-y

30 December 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00198-003-1399-Y

Osteoporosis International

30 December 2023

published in

1 reference

2 December 2017

volume

14

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

507-514

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-003-1399-y

2 December 2017

exact match

0 references

cites work

Prescription-event monitoring--recent progress and future horizons

1 reference

12 December 2020

Bisphosphonates in the treatment of metabolic bone diseases

1 reference

12 December 2020

Esophagitis associated with the use of alendronate

1 reference

12 December 2020

General practice postal surveys: a questionnaire too far?

1 reference

12 December 2020

Tolerability of alendronate. Figures given in letter were prevalences, not incidences

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Tolerability of alendronate. Comparison group taking placebo should have been included

1 reference

12 December 2020

Tolerability of alendronate. Manufacturer's comment

1 reference

12 December 2020

Introduction to bone biology

1 reference

12 December 2020

Pamidronate: an unrecognized problem in gastrointestinal tolerability

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Prescriber profile and post-marketing surveillance

1 reference

12 December 2020

Incidence of gastrointestinal side effects due to alendronate is high in clinical practice

1 reference

12 December 2020

Surveying general practitioners: does a low response rate matter?

1 reference

12 December 2020

The prevention and treatment of osteoporosis

1 reference

12 December 2020

Identifiers

DOI

1 reference

2 December 2017

1 reference